Lantheus Holdings, Inc. (LNTH): Price and Financial Metrics


Lantheus Holdings, Inc. (LNTH): $61.27

0.02 (+0.03%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LNTH POWR Grades

  • Growth is the dimension where LNTH ranks best; there it ranks ahead of 93.26% of US stocks.
  • LNTH's strongest trending metric is Quality; it's been moving up over the last 179 days.
  • LNTH's current lowest rank is in the Stability metric (where it is better than 18.93% of US stocks).

LNTH Stock Summary

  • LNTH's current price/earnings ratio is 39.16, which is higher than 84.15% of US stocks with positive earnings.
  • Over the past twelve months, LNTH has reported earnings growth of -703.78%, putting it ahead of only 2.55% of US stocks in our set.
  • Revenue growth over the past 12 months for LANTHEUS HOLDINGS INC comes in at 105.61%, a number that bests 92.14% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to LNTH, based on their financial statements, market capitalization, and price volatility, are SSTK, TECH, APPS, OSIS, and ZIP.
  • Visit LNTH's SEC page to see the company's official filings. To visit the company's web site, go to www.lantheus.com.

LNTH Valuation Summary

  • LNTH's price/sales ratio is 5; this is 150% higher than that of the median Healthcare stock.
  • Over the past 90 months, LNTH's price/earnings ratio has gone up 87.8.

Below are key valuation metrics over time for LNTH.

Stock Date P/S P/B P/E EV/EBIT
LNTH 2022-11-25 5.0 6.3 37.6 23.4
LNTH 2022-11-23 5.0 6.3 37.8 23.5
LNTH 2022-11-22 5.0 6.2 37.2 23.2
LNTH 2022-11-21 4.9 6.2 36.9 23.0
LNTH 2022-11-18 5.0 6.2 37.1 23.1
LNTH 2022-11-17 4.7 5.9 35.4 22.0

LNTH Growth Metrics

    Its 5 year revenue growth rate is now at 16.46%.
  • Its 4 year cash and equivalents growth rate is now at 87.02%.
  • The year over year revenue growth rate now stands at 58.72%.
LNTH's revenue has moved up $472,072,000 over the prior 52 months.

The table below shows LNTH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 801.457 190.318 107.037
2022-06-30 664.238 101.09 32.39
2022-03-31 541.579 54.362 -37.325
2021-12-31 425.208 53.916 -71.279
2021-09-30 389.798 40.596 -34.476
2021-06-30 376.269 44.831 -27.447

LNTH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • LNTH has a Quality Grade of C, ranking ahead of 29.96% of graded US stocks.
  • LNTH's asset turnover comes in at 0.436 -- ranking 105th of 682 Pharmaceutical Products stocks.
  • AVDL, OTIC, and SYRS are the stocks whose asset turnover ratios are most correlated with LNTH.

The table below shows LNTH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.436 0.431 -0.030
2021-03-31 0.393 0.416 0.016
2020-12-31 0.448 0.409 -0.004
2020-09-30 0.521 0.432 0.006
2020-06-30 0.634 0.452 0.034
2020-03-31 0.877 0.480 0.075

LNTH Price Target

For more insight on analysts targets of LNTH, see our LNTH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $32.00 Average Broker Recommendation 1.17 (Strong Buy)

LNTH Stock Price Chart Interactive Chart >

Price chart for LNTH

LNTH Price/Volume Stats

Current price $61.27 52-week high $87.47
Prev. close $61.25 52-week low $23.51
Day low $60.88 Volume 484,400
Day high $62.16 Avg. volume 1,156,658
50-day MA $65.94 Dividend yield N/A
200-day MA $65.55 Market Cap 4.22B

Lantheus Holdings, Inc. (LNTH) Company Bio


Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic medical imaging agents and products for the diagnosis and treatment of cardiovascular and other diseases worldwide. The company was founded in 1956 and is based in North Billerica, Massachusetts.


LNTH Latest News Stream


Event/Time News Detail
Loading, please wait...

LNTH Latest Social Stream


Loading social stream, please wait...

View Full LNTH Social Stream

Latest LNTH News From Around the Web

Below are the latest news stories about LANTHEUS HOLDINGS INC that investors may wish to consider to help them evaluate LNTH as an investment opportunity.

Lantheus Announces the Approval of DEFINITY® (Perflutren Lipid Microsphere) by China’s NMPA

DEFINITY is the leading diagnostic ultrasound enhancing agent for patients with suboptimal echocardiogramsNORTH BILLERICA, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, today announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products Ad

Yahoo | November 28, 2022

7 Index Funds to Buy to Retire a Millionaire

Although the market shows signs of improvement, the waters are still choppy enough for investors to focus on index funds to buy.

Josh Enomoto on InvestorPlace | November 23, 2022

Zacks Industry Outlook Highlights QuidelOrtho, Lantheus and TG Therapeutics

QuidelOrtho, Lantheus and TG Therapeutics are part of Zacks Industry Outlook article.

Yahoo | November 21, 2022

3 Stocks That Could Be the Next Big M&A Targets

These three potential M&A deals run the gamut from very possible to very unlikely, despite the benefits of a transaction getting done.

Will Ashworth on InvestorPlace | November 18, 2022

These 3 Stocks Are Crushing the Market. Wall Street Thinks They Can Soar at Least 78% Higher.

The share price of Lantheus Holdings (NASDAQ: LNTH) has nearly doubled in 2022. Much of the gain for the stock came after Lantheus reported its 2021 Q4 results in late February. Lantheus develops imaging diagnostics, targeted therapeutics, and artificial intelligence (AI) solutions for discovering and treating serious medical conditions.

Yahoo | November 18, 2022

Read More 'LNTH' Stories Here

LNTH Price Returns

1-mo 2.03%
3-mo -21.93%
6-mo -12.57%
1-year 131.21%
3-year 203.32%
5-year 195.28%
YTD 112.08%
2021 114.16%
2020 -34.23%
2019 31.05%
2018 -23.47%
2017 137.79%

Continue Researching LNTH

Here are a few links from around the web to help you further your research on Lantheus Holdings Inc's stock as an investment opportunity:

Lantheus Holdings Inc (LNTH) Stock Price | Nasdaq
Lantheus Holdings Inc (LNTH) Stock Quote, History and News - Yahoo Finance
Lantheus Holdings Inc (LNTH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7252 seconds.